Press Release

Cardiac Troponin Market 2020 | Size, Share, Regional Growth Analysis, Industry Outlook and Forecast 2026

Cardiac Troponin Market 2020 | Industry Trends, Growth Drivers, Competitive Landscape, Regional Analysis 2026

As per a report by Fortune Business Insights, titled “Cardiac Troponin Market Size”, Share and Global Trend By Type (Troponin T, Troponin I), By Site Of Testing (Laboratory-based, Point-of-care), By Application (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure), By End User (Hospitals, Diagnostic Centers, Homecare Settings) and Geography Forecast till 2026,” the market is categorized on the basis of application, site of testing, type, end-user, and geography.

The World Health Organization stated that nearly 31% of all global deaths, i.e., 17.9 million people, died from cardiovascular diseases in 2016. Among these, about 85% deaths are caused due to heart attack. The rise in geriatric population and their vulnerability towards various acute and chronic diseases, especially of the heart is promoting the cardiac troponin market growth, predicts Fortune Business Insights in their new report. Cardiac troponins are certain sensitive indicators of damage to the myocardium (heart muscle) and are measured in the blood. They are used for differentiating between myocardial infarction (heart attack) and unstable angina among people complaining about chest pain or having the acute coronary syndrome.

For more information in the analysis of this report, visit:

Key Players Operating in The Cardiac Troponin Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • BioMérieux SA.
  • Hoffmann-La Roche Ltd
  • Beckman Coulter, Inc.
  • Abbott
  • Eurolyser Diagnostica GmbH
  • Tulip Diagnostics (P) Ltd
  • Siemens Healthcare GmbH
  • Response Biomedical Corp.
  • LSI Medience Corporation

Surge in Cardiovascular Disease Cases to Help Promote Growth of Market

The increasing cases of cardiovascular diseases and the need to diagnose them are one of the major factors boosting the global cardiac troponin market. There is a surge in demand for cardiac biomarkers to treat cardiovascular diseases and this will also help to generate cardiac troponin market revenues in the coming years. Besides this, the surge in prevalence of acute coronary syndrome will also help the market gain traction, since patients with acute critical heart conditions need quicker diagnosis and faster results. This further increase the demand for advanced cardiac troponins, and their increasing demand will thus, bring promising growth to the market globally.

Request a Sample Copy of the Research Report:

Improving Healthcare Facilities to Aid in Expansion of Market in Asia Pacific and Europe

Geographically, the global cardiac troponin market growth in North America is seen to be dominant owing to the presence of major players and presence of advanced technology in developed nations such as Canada and the United States. On the other side, the rising prevalence of cardiovascular diseases, and improving healthcare and medical infrastructure and technological advancement in Europe and the Asia Pacific are likely to help these regions rise significantly. This, accompanied by the increasing per capita income of people and their willingness to spend more on better healthcare facilities will also help the market attract high revenues in near future.

Medical Lifting Slings Market Segmentation

By Type

  • Troponin T
  • Troponin I

By Site Of Testing

  • Laboratory-based
  • Point-of-care

By Application

  • Acute Coronary Syndrome
  • Myocardial Infarction
  • Congestive Heart Failure
  • Others

By End User

  • Hospitals
  • Diagnostic Centers
  • Homecare Settings
  • Others

By Geography

  • North America (the USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Have Any Query? Ask Our Experts:

Report Focus:

  • Extensive product offerings
  • Customer research services
  • Robust research methodology
  • Comprehensive reports
  • Latest technological developments
  • Value chain analysis
  • Potential Cardiac Troponin Market opportunities
  • Growth dynamics
  • Quality assurance
  • Post-sales support
  • Regular report updates

Reasons to Purchase this Report:

  • Comprehensive analysis of the Cardiac Troponin Market growth drivers, obstacles, opportunities, and other related challenges.
  • Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
  • Identifies market restraints and boosters.
  • Identifies all the possible segments present in the market to aid organizations in strategic business planning.


  • What is the market size and growth rate of the global and regional market by various segments?
  • What is the market size and growth rate of the market for selective countries?
  • Which region or sub-segment is expected to drive the market in the forecast period?
  • What Factors are estimated to drive and restrain the Cardiac Troponin Market growth?
  • What are the key technological and market trends shaping the market?
  • What are the key opportunities in the market?
  • What are the key companies operating in the market?
  • Which company accounted for the highest market share?

Related Reports:

In vitro Diagnostics Market 2020 Global Industry Share, Size, Regional Growth Analysis and 2026 Forecast

In vitro Diagnostics Market 2020 Global Industry Share, Size, Regional Growth Analysis and 2026 Forecast

In vitro Diagnostics Market 2020 Global Industry Share, Size, Regional Growth Analysis and 2026 Forecast

In vitro Diagnostics Market 2020 Global Industry Share, Size, Regional Growth Analysis and 2026 Forecast

In vitro Diagnostics Market 2020 Global Industry Share, Size, Regional Growth Analysis and 2026 Forecast

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Linkedin | Twitter | BLogs

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *